Blood Test Shows Promise for Detecting Cancers Without Approved Screening Tests
A novel blood test can detect cancers that currently have no standard screening procedures, a study suggests.
A novel blood test can detect cancers that currently have no standard screening procedures, a study suggests.
New data highlight the high cost of targeted oral anticancer medicines for patients with Medicare Part D coverage.
Sublobar resection is noninferior to a full lobectomy in patients with carefully staged cT1aN0 non-small cell lung cancer, new research suggests.
An expert outlines ways to improve outcomes for older patients with ovarian cancer.
The expansion of Medicaid eligibility was associated with a nearly 3-fold increase in the proportion of Medicaid-covered patients enrolled in cancer treatment trials.
Having a high-deductible health plan was associated with a nearly 5-month delay in the diagnosis of metastatic cancer.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of Peutz-Jeghers syndrome.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesakes of von Hippel-Lindau disease.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of the Bence-Jones protein.
The 2-year overall survival rate was 32.5%.